NSE NH · BSE 539551 · Healthcare Facilities · NIFTY 500
Narayana Hrudayalaya Share Price
₹1,789.90
▼ −₹30.21 · 1.66%
Day range · 29 Sep
₹1,764.00Low₹1,861.90High
52-week range
₹1,564.25Low · 2 Apr 2026₹2,094.30High · 17 Nov 2025
Narayana Hrudayalaya Overview
Where the price stands, how it has moved and how it sits against its averages.
Narayana Hrudayalaya shares last traded at ₹1,789.90 on the NSE, down 1.66% on the day. That is 14.5% below the 52-week high of ₹2,094.30 and 14.4% above the 52-week low of ₹1,564.25. The stock trades at 44.73× earnings, above the sector average of 30.19. Its market value is ₹36,503 Cr.
Price returns
1 Day▼ −1.66%
1 Week▼ −4.96%
This month▼ −6.15%
3 Months▼ −5.94%
6 Months▲ +9.44%
This year▼ −5.40%
1 Year▲ +0.96%
Share price growth a year (CAGR): 3 years ▲ +18.1% · 5 years ▲ +28.0% · 10 years ▲ +19.0%
Against the market: 1 Month ▲ +0.92% · 3 Months ▲ +0.85% · 6 Months ▲ +12.10% · This year ▲ +12.66% · 1 Year ▲ +16.61%
Shading grows with the size of the move. We ask our data provider for a newer price every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next check from Fri 16 Oct, 9:15 AM. Its quotes are not real-time — the time at the top shows how current the price is.
Moving averages — price is above 0 of 6
- 100-day average₹1,915.20 ▼ price 6.5% below
- 50-day average₹1,908.67 ▼ price 6.2% below
- 20-day average₹1,895.12 ▼ price 5.6% below
- 5-day average₹1,887.72 ▼ price 5.2% below
- 10-day average₹1,885.14 ▼ price 5.1% below
- 300-day average₹1,857.53 ▼ price 3.6% below
- Today's price₹1,789.90
Each average is the mean closing price over that many trading days; averages above the current price sit higher on the ladder.
Narayana Hrudayalaya Financial Results
Revenue and net profit in ₹ crore, with the full statements underneath.
7,896
−14
806
Year by year
| Fiscal year | Revenue | Growth | Net profit | Net margin | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2026 | ₹7,896 Cr | ▲ +44.0% | ₹806 Cr | 10.2% | ₹39.89 | ₹4.50 |
| FY 2025 | ₹5,483 Cr | ▲ +12.1% | ₹790 Cr | 14.4% | ₹38.86 | ₹4.50 |
| FY 2024 | ₹4,890 Cr | ▲ +8.1% | ₹789 Cr | 16.1% | ₹38.68 | ₹4.00 |
| FY 2023 | ₹4,525 Cr | ▲ +22.2% | ₹606 Cr | 13.4% | ₹29.85 | — |
| FY 2022 | ₹3,701 Cr | ▲ +43.3% | ₹342 Cr | 9.2% | ₹16.84 | ₹1.00 |
| FY 2021 | ₹2,582 Cr | ▼ −17.4% | −₹14 Cr | −0.6% | −₹0.70 | ₹0.00 |
| FY 2020 | ₹3,128 Cr | — | ₹119 Cr | 3.8% | ₹5.86 | ₹1.00 |
2,684
258
207
Quarter by quarter
| Quarter | Revenue | vs prev. qtr | Net profit | Net margin | EPS |
|---|---|---|---|---|---|
| Q1 FY27 | ₹2,684 Cr | ▲ +3.5% | ₹207 Cr | 7.7% | ₹10.20 |
| Q4 FY26 | ₹2,594 Cr | ▲ +20.6% | ₹224 Cr | 8.6% | ₹11.20 |
| Q3 FY26 | ₹2,151 Cr | ▲ +30.9% | ₹127 Cr | 5.9% | ₹6.36 |
| Q2 FY26 | ₹1,644 Cr | ▲ +9.1% | ₹258 Cr | 15.7% | ₹12.71 |
| Q1 FY26 | ₹1,507 Cr | ▲ +9.6% | ₹197 Cr | 13.0% | ₹9.65 |
| Q4 FY25 | ₹1,375 Cr | ▲ +0.6% | ₹197 Cr | 14.3% | ₹9.67 |
| Q3 FY25 | ₹1,367 Cr | ▲ +4.6% | ₹193 Cr | 14.1% | ₹9.50 |
| Q1 FY25 | ₹1,306 Cr | — | ₹201 Cr | 15.4% | ₹9.88 |
Balance sheet — FY26
Owes (liabilities)Shareholders' equity
64%
36%
- Total assets₹12,474 Cr
- Total liabilities₹7,937 Cr
- Shareholders' equity₹4,537 Cr
- Total debt₹5,858 Cr
- Cash & investments₹1,519 Cr
- Current ratio2.15×
- Revenue growth, 5 yr25.05% a year
- Operating margin (TTM)12.99%
- Net margin (TTM)9.06%
Cash flow — FY26
Operating activities
▲ ₹1,668 Cr
Investing activities
▼ −₹3,700 Cr
Financing activities
▲ ₹2,340 Cr
Free cash flow
▲ ₹793 Cr
Net change in cash
▲ ₹313 Cr
Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.
Full financial statements, FY20–FY26
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total revenue | 3,127.81 | 2,582.35 | 3,701.32 | 4,524.77 | 4,890.21 | 5,482.98 | 7,896.04 |
| Cost of revenue | 1,732.83 | 1,540.13 | 1,989.34 | 2,288.33 | 2,378.61 | 2,614.70 | 3,375.82 |
| Gross profit | 1,394.98 | 1,042.22 | 1,711.98 | 2,236.44 | 2,511.60 | 2,868.28 | 4,520.21 |
| Operating expenses | 2,900.02 | 2,577.06 | 3,220.10 | 3,746.50 | 3,974.39 | 4,483.75 | 6,760.87 |
| Operating income | 227.79 | 5.29 | 481.22 | 778.27 | 915.81 | 999.23 | 1,135.17 |
| Depreciation | 185.80 | 183.53 | 183.48 | 210.04 | 241.48 | 278.11 | 447.80 |
| Profit before tax | 161.31 | −56.07 | 429.78 | 751.58 | 883.99 | 935.54 | 968.81 |
| Tax | 42.25 | −41.77 | 87.66 | 145.01 | 98.00 | 145.72 | 158.36 |
| Net profit | 118.92 | −14.30 | 341.93 | 606.25 | 789.26 | 790.16 | 805.60 |
| EPS (₹) | 5.86 | −0.70 | 16.84 | 29.85 | 38.68 | 38.86 | 39.89 |
| Dividend per share (₹) | 1.00 | 0.00 | 1.00 | — | 4.00 | 4.50 | 4.50 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total assets | 2,891.06 | 2,770.02 | 3,130.53 | 4,162.09 | 5,624.58 | 7,265.03 | 12,474.40 |
| Current assets | 586.42 | 665.13 | 909.00 | 1,293.93 | 1,946.06 | 2,549.84 | 3,932.14 |
| Cash & short-term investments | 172.01 | 220.74 | 288.72 | 406.21 | 1,236.81 | 1,607.77 | 1,518.81 |
| Inventory | 71.76 | 57.20 | 74.32 | 109.57 | 139.77 | 158.06 | 221.70 |
| Property, plant & equipment | 1,983.57 | 1,867.58 | 1,942.48 | 2,315.74 | 2,916.54 | 4,109.49 | 5,639.10 |
| Total liabilities | 1,755.10 | 1,649.74 | 1,641.90 | 2,030.71 | 2,740.90 | 3,638.67 | 7,937.15 |
| Current liabilities | 601.92 | 703.24 | 780.24 | 987.27 | 1,110.38 | 1,193.14 | 1,827.25 |
| Total debt | 952.21 | 825.64 | 723.42 | 884.17 | 1,626.69 | 2,428.37 | 5,857.50 |
| Total equity | 1,135.96 | 1,120.28 | 1,488.64 | 2,131.38 | 2,883.68 | 3,626.36 | 4,537.26 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| From operations | 443.34 | 309.05 | 485.02 | 1,084.56 | 1,066.60 | 985.78 | 1,667.68 |
| From investing | −188.54 | −112.99 | −266.91 | −1,174.10 | −1,457.94 | −1,325.32 | −3,699.90 |
| From financing | −246.95 | −198.43 | −158.95 | 87.74 | 488.45 | 544.31 | 2,340.43 |
| Capital expenditure | −115.89 | −70.10 | −250.68 | −522.04 | −970.61 | −1,081.96 | −875.18 |
| Dividends paid | −48.97 | 0.00 | — | −20.30 | −50.77 | −81.24 | −91.00 |
| Net change in cash | 7.49 | −2.34 | 59.02 | −3.93 | 97.15 | 205.42 | 313.41 |
Narayana Hrudayalaya vs Peers
Side by side with other healthcare facilities companies. The small bars compare each column.
| Company | Price | Change | Market cap | P/E | P/B | ROE (5 yr) | Net margin | Div. yield |
|---|---|---|---|---|---|---|---|---|
| Narayana Hrudayalaya This stock | ₹1,789.90 | ▼ −1.66% | ₹36,503 Cr | 44.73 | 8.01 | 25.72% | 9.06% | 0.25% |
| Apollo Hospitals Enterprise | ₹8,701.90 | ▼ −1.81% | ₹1,25,120 Cr | 64.93 | 13.39 | 18.12% | 7.76% | 0.23% |
| Max Healthcare Institute | ₹983.95 | ▼ −1.69% | ₹95,769 Cr | 71.47 | 9.87 | 13.32% | 17.23% | 0.18% |
| Fortis Healthcare | ₹819.00 | ▼ −1.52% | ₹61,831 Cr | 67.89 | 7.27 | 9.36% | 11.66% | 0.10% |
| Aster DM Healthcare | ₹735.30 | ▼ −1.67% | ₹64,175 Cr | 102.55 | 9.26 | 7.13% | 9.20% | 0.49% |
| Global Health | ₹1,424.00 | ▼ −0.68% | ₹38,440 Cr | 63.65 | 8.93 | 15.69% | 12.56% | 0.04% |
Peer prices and ratios as last reported by the data provider. Company names link to their own pages.
Narayana Hrudayalaya Key Metrics
Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.
Narayana HrudayalayaBenchmarkRule-of-thumb bands
Valuation The price against earnings, book value and sales
P/E (TTM)Price ÷ yearly earnings per share
44.73
▲ 48% above the sector average of 30.19
P/E, 12-month rangeLow 25.94 · high 56.19
62%
Today's P/E sits 62% of the way from its low to its high
P/BPrice ÷ book value per share
8.01
P/SMarket cap ÷ last 12 months' revenue
4.02
P/CFPrice ÷ cash flow per share
27.56
PEGP/E ÷ earnings growth rate
4.46
Profitability Of every ₹100 of sales, how much is kept?
Gross marginKept after the cost of goods
67.97%
▲ above its 5-yr average of 52.27%
Operating marginKept after running costs
12.99%
▼ below its 5-yr average of 16.27%
Pre-tax marginKept before tax
11.00%
▼ below its 5-yr average of 14.98%
Net marginKept as profit
9.06%
▼ below its 5-yr average of 12.59%
Returns & efficiency How well does it use its money?
Return on equityProfit on shareholders' money
19.85%
▼ below its 5-yr average of 25.72%
Return on assetsProfit on everything it owns
8.21%
▼ below its 5-yr average of 11.99%
Return on investmentProfit on long-term capital
9.70%
▼ below its 5-yr average of 14.85%
Return on capital employedProfit before interest and tax on equity + debt
13.88%
Growth Is the business getting bigger?
Revenue — last 12 months
+61.6%
▲ growing (off the scale)
Revenue — 3 yr, a year
+20.4%
▲ growing
Revenue — 5 yr, a year
+25.1%
▲ growing (off the scale)
Net profit — 3 yr, a year
+9.9%
▲ growing
EPS — last 12 months
+4.8%
▲ growing
EPS — 3 yr, a year
+10.1%
▲ growing
Book value — 5 yr, a year
+32.4%
▲ growing (off the scale)
Financial strength Can it pay its bills and debts?
Debt to equityBorrowings for every ₹1 of shareholders' money
1.29×
Current ratioShort-term assets for every ₹1 due within a year
2.15×
Quick ratioLike the current ratio, without inventory
2.03×
Interest coverOperating profit ÷ interest to pay
6.86×
Payout ratioShare of profit paid as dividend
11.28%
Per share What each share stands for
EPS (TTM)
₹40.22
Book value
₹223.40
Cash flow
₹66.17
Dividend
₹4.50
Revenue
₹447.56
The share price is 8.01× the book value behind each share.
Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.
All 107 metrics from the data provider
Valuation
P/E excluding extraordinary items, most recent fiscal year45.63
Current Dividend Yield - Common Stock Primary Issue, LTM0.25
Price to Book - most recent fiscal year8.15
P/E Basic excluding extraordinary items - TTM48.71
P/E including extraordinary items - TTM45.25
P/E excluding extraordinary items low, trailing 12 months25.94
Price to Tangible Book - most fiscal year17.70
Price to sales - most recent fiscal year4.68
Dividend Yield - indicated annual dividend divided by closing price0.25
Price to Cash Flow per share - trailing 12 month27.56
Peg Ratio4.46
Price to Free Cash Flow per Share - most recent fiscal year52.70
P/E Normalized, most recent fiscal year43.02
P/E excluding extraordinary items high, trailing 12 months56.19
P/E excluding extraordinary items, most recent fiscal year quarter44.97
Price to sales - trailing 12 month4.07
Net Debt, LFY43,386.82
Per share
Cash Flow per share - trailing 12 month66.17
Cash Flow per share - most recent fiscal year61.95
EPS including extraordinary items - trailing 12 month40.22
EPS including extraordinary items - most recent fiscal year39.67
EBITD per share - trailing 12 month86.30
Revenue/share - trailing 12 month447.56
EPS excluding extraordinary items - trailing 12 month40.48
EPS Basic excluding extraordinary items - most recent fiscal year39.89
EPS Basic excluding extraordinary items - trailing 12 month40.48
Book value per share - most recent fiscal year223.40
Dividend per share - most recent fiscal year4.50
Revenue/share - most recent fiscal year388.78
EPS Normalized - most recent fiscal year42.31
Book value (tangible) per share - most recent fiscal year102.84
Dividends per share - trailing 12 month4.50
EPS excluding extraordinary items - most recent fiscal year39.89
Cash per share - most recent fiscal year74.78
Margins
Operating margin - trailing 12 month12.99
Gross Margin - 5 year average52.27
Operating margin - 1st historical fiscal year14.38
Operating Margin - 5 year average16.27
Net Profit Margin % - 1st historical fiscal year10.26
Gross Margin - 1st historical fiscal year57.25
Net Profit Margin % - trailing 12 month9.06
Net Profit Margin - 5 year average12.59
Pretax Margin - 5 year average14.98
Pretax margin - 1st historical fiscal year12.27
Pretax margin - trailing 12 month11.00
Free Operating Cash Flow/Revenue, 5 Year Average5.08
Gross Margin - trailing 12 month67.97
Growth
EPS Change %, TTM over TTM4.79
Revenue growth rate, 5 year25.05
Revenue Change % - most recent quarter 1 year ago78.05
Growth rate% - EPS, 3 year10.14
Revenue/share (5 yr growth)25.03
Free Operating Cash Flow, 5 Year CAGR24.03
Tangible Book Value, Total Equity, 5 Year CAGR15.83
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR33.88
Capital Spending growth rate, 5 year65.68
Revenue Change %, TTM over TTM61.55
Growth rate% - Revenue, 3 year20.39
Book value per share growth rate, 5 year32.44
EPS Change % - most recent quarter 1 year ago5.72
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR53.97
Total Debt, 5 Year CAGR47.97
Financial strength
Net Interest coverage - most recent fiscal year6.86
Free Cash Flow - most recent fiscal year7,014.94
LT debt/equity - most recent fiscal year1.22
Quick ratio - most recent fiscal year2.03
Payout ratio - trailing 12 month11.13
Current ratio - most recent fiscal year2.15
Current EV/Free Cash Flow, LFY141.42
Total debt/total equity - most recent fiscal year1.29
Net Interest coverage - trailing 12 month4.21
Payout ratio - most recent fiscal year11.35
Returns & efficiency
Return on average equity - 5 year average25.72
Net Income/employee - trailing 12 month7,23,117.10
Revenue/employee - most recent fiscal year69,34,254.00
Return on investment - most recent fiscal year9.70
Return on average assets - most recent fiscal year8.21
Receivables turnover - most recent fiscal year9.83
Inventory turnover - most recent fiscal year17.78
Revenue/employee - trailing 12 month79,84,159.00
Return on average assets - 5 year average11.99
Net Income/employee - most recent fiscal year7,11,740.60
Asset turnover - most recent fiscal year0.80
Return on average equity - most recent fiscal year19.85
Return on investment - 5 year average14.85
Price & volume
Market Cap36,773.74
52 week Low Date2 Apr 2026
Price - 1 Day % Change−2.22
Relative (S&P500) price percent change - 13 week0.85
Avg trading volume last 10 days0.16
Price - 13 week price percent change−4.35
Price - 52 week price percent change5.51
Avg Trading Volume Last 3 months5.72
Price - 5 Day % Change−4.05
Price % Change Month To Date−4.57
Relative (S&P500) price percent change - 04 week0.92
52 week High Date17 Nov 2025
Price - 26 week price percent change13.38
PDATE28 Sep 2026
Price - YTD price percent change−3.80
Relative (S&P500) price percent change - 52 week16.61
NPRICE1,820.10
Relative (S&P500) price percent change - 26 week12.10
52 week Low1,589.00
52 week High2,093.30
Beta0.86
Relative (S&P500) price percent change - Year to Date12.66
Dividends & Corporate Events
Payouts to shareholders, splits and bonus issues, and company meetings — newest first.
₹4.50
₹4.50
- Dividend yield0.25%
- Payout ratio11.28%
- Latest dividend₹4.50 per share · 17 Jul 2026
Corporate calendar
- MeetingPostal Ballot
- MeetingAnnual General Meeting
- BoardQuarterly Results
- Dividend₹4.50 per share · 45% · Final dividend
- BoardAudited Results & Final Dividend
- MeetingCOM
- BoardQuarterly Results
- MeetingCOM
Show 11 older events
- BoardQuarterly Results
- MeetingAnnual General Meeting
- Dividend₹4.50 per share · 45% · Final dividend
- BoardQuarterly Results & Fund Raising
- BoardAudited Results, Final Dividend & Others
- BoardQuarterly Results
- MeetingPostal Ballot
- BoardQuarterly Results
- Dividend₹4.00 per share · 40% · Final dividend
- Dividend₹2.50 per share · 25% · Final dividend
- Dividend₹1.00 per share · 10% · Final dividend
About Narayana Hrudayalaya
Healthcare Facilities
Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental and behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of over 18 hospitals and three heart centers across India, along with an international presence in the Cayman Islands.
Key people
- Devi Prasad ShettyExecutive Chairman of the Board, Whole Time Director
- Emmanuel RupertGroup Chief Executive Officer, Managing Director, Executive Director
- Viren Prasad ShettyExecutive Vice Chairman of the Board
- Sandhya JayaramanGroup Chief Financial Officer
- Sridhar SeshiahGroup Company Secretary, Legal and Compliance Officer
Company facts
- NSE symbolNH
- BSE code539551
- ISININE410P01011
- IndustryHealthcare Facilities
- IndexNIFTY 500
- Market cap₹36,503 Cr
- Revenue (FY26)₹7,896 Cr
- Net profit (FY26)₹806 Cr
Stock data comes from the exchange feed via our data provider. It is not real-time and can be delayed, so check the price with your broker before you trade. This page is for information and education only. It is not investment advice, research or a recommendation to buy, sell or hold any security. Investments in the securities market are subject to market risks; read all related documents carefully before investing. See all stocks →
Frequently Asked Questions
Narayana Hrudayalaya (NSE: NH) last traded at ₹1,789.90 on the NSE, down 1.66% (₹30.21) on the day, as of 29 Sep 2026. The day's range was ₹1,764.00 – ₹1,861.90.
Narayana Hrudayalaya's 52-week high is ₹2,094.30 (17 Nov 2025) and its 52-week low is ₹1,564.25 (2 Apr 2026). At ₹1,789.90 the share is 14.5% below its high and 14.4% above its low.
Narayana Hrudayalaya's market capitalisation is ₹36,503 Cr (₹36,503 Cr). It is part of the NIFTY 500 index.
Narayana Hrudayalaya's P/E ratio (trailing 12 months) is 44.73. The sector average is 30.19, so investors pay 48% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹40.22.
Narayana Hrudayalaya shares are up 0.96% over the last year, down 5.40% so far this year, up 9.44% over 6 months, down 5.94% over 3 months. Over the last year the stock did 16.61% better than the market.
In FY26 (year to Mar 2026), Narayana Hrudayalaya reported revenue of ₹7,896 Cr (up 44.01% on the year before) and a net profit of ₹806 Cr. Earnings per share were ₹39.89.
Yes. Narayana Hrudayalaya's latest dividend is ₹4.50 per share (45%, final dividend), with an ex-date of 17 Jul 2026. The dividend yield is 0.25%. It has paid 5 dividends in the records shown on this page.
As of Jun 2026: Promoter 63.27%, FII 9.40%, MF 7.34%, Other 19.99%.
Narayana Hrudayalaya's listed peers in Healthcare Facilities include Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare, Global Health. By market capitalisation it ranks #6 of 6 in this group.
No. Narayana Hrudayalaya has debt — its debt-to-equity ratio is 1.29 and total debt was ₹5,858 Cr in FY26. Its operating profit covers interest 6.86 times.